ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Concept Life Sciences, an English drug discovery, development, and analytical services company, has acquired Aquila BioMedical, a Scottish preclinical contract research organization (CRO). Aquila focuses on drug development services in oncology, biomarker discovery, and target expression. CiToxLAB Group, a nonclinical CRO based in Evreux, France, purchased Xenometrics, a Stilwell, Kan.-basedCRO. It is the French firm’s third acquisition in North America, following LAB Research Group in 2011 and AccelLAB last year. And Almac Group of Northern Ireland acquired BioClin Laboratories, an Irish analytical services firm specializing in microbiology and bioanalysis.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X